Wolfgang Miesbach: New Research Reveals Clonogenic Hepatocytes as the Key Drivers of Liver Growth and Gene Therapy Success
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Only 15-20% of newborn hepatocytes generate 90% of adult liver tissue. New research from San Raffaele Telethon Institute characterizes hepatocyte heterogeneity and reveals that ‘clonogenic hepatocytes‘ – a small subset of liver cells in newborn mice – are responsible for most adult liver growth:
- Gene editing by HDR preferentially targets these clonogenic cells, expanding edited liver areas during growth
- Lentiviral vectors show age-dependent efficiency – higher in newborns, lower in adults (reversible with proteasome inhibition)
- Peri-central hepatocyte identity develops after weaning
- Clonogenic hepatocytes co-localize with hematopoietic progenitor cells in specialized tissue niches research
Gene Therapy Impact:
This discovery transforms pediatric gene therapy timing and targeting strategies. Understanding when and which hepatocytes to target could unlock more effective treatments for inherited liver diseases
The team used cutting-edge single-cell/spatial transcriptomics, clonal tracing, and mathematical modeling to map hepatocyte proliferation and maturation after birth
Congratulations to Alessio Cantore, Michela Milani, Francesco Starinieri, Matteo Iannacone, Renato Ostuni, Giulia Bortolussi, Ivan Merelli, Stefano Beretta, Marco Monti!”
Title: Spatiotemporal liver dynamics shape hepatocellular heterogeneity and impact in vivo gene engineering
Authors: Michela Milani, Francesco Starinieri, Stefano Beretta, Marco Monti, Cesare Canepari, Francesca Marabotti, Samuel Zambrano, Davide Mazza, Anna Fabiano, Chiara Simoni, Eugenia Cammarota, Monica Volpin, Giulia Bortolussi, Fabio Russo, Mauro Biffi, Marco Genua, Sara Degl’Innocenti, Francesca Sanvito, Renato Ostuni, Andrés F. Muro, Eugenio Montini, Federica Moalli, Matteo Iannacone, Ivan Merelli, Alessio Cantore
Read the full article here.
More recent insights on Hemostasis Today.
-
Oct 18, 2025, 16:59Raul Santos Gave 2 Talks at SAC 2025: On The Role of LDL-C and Future of Lipid-lowering Therapies
-
Oct 18, 2025, 16:57Marilena Vrana: What An Inspiring Week at The 2025 Plasma Protein Forum and Business Forum
-
Oct 18, 2025, 16:53Caitlin Raymond: When Technology Meets Physiology in Neonatal Patients
-
Oct 17, 2025, 08:37Salome Mekhuzla Invites You to Join WHO Essential Medicines List 2025 Updates Webinar on Hemophilia and VWD
-
Oct 17, 2025, 08:36Plasma Protein Forum 2025: From Anti-D Plasma and Blood Supply Incentives to the Future of AI
-
Oct 18, 2025, 16:56Alexandra Whiteside on Improving Coagulation Kinetics
-
Oct 18, 2025, 16:52Wolfgang Miesbach on Differential Diagnosis of Thrombocytopenia
-
Oct 18, 2025, 16:49Arisa Chuklin, Thita Joy Chiasakul, and Noppacharn Uaprasert on Management of Thrombosis in Behçet’s Syndrome
-
Oct 18, 2025, 16:47State of the Art Review On Angina After PCI From Javier Escaned's Team
-
Oct 18, 2025, 16:25Luciana Werneck Zuccherato and Colleagues on A3 domain of FVIII in Severe Hemophilia A
-
Oct 16, 2025, 06:07ClearPlasma - A New Breakthrough in Stopping Life-Threatening Bleeds
-
Oct 14, 2025, 05:26Ryan C. Heniford: Every Thrombus Prevented Is a Patient Protected
-
Oct 13, 2025, 04:48Archil Jaliashvili showcases how BHOC builds on Hemopure’s success to revolutionize surgery and care
-
Oct 13, 2025, 02:46Flora Peyvandi: First Proposed Blood Test for Chronic Fatigue Syndrome - What Scientists Think
-
Oct 13, 2025, 02:44Silvio Maresca: Honored to be part of this international research project - ThrombUS+
-
Oct 18, 2025, 16:55Emilia Arturo: Your Reminder to Donate Blood If You Can, When You Can
-
Oct 18, 2025, 16:51Allison Wheeler Rallies Support for Magdalena Lewandowska's NYC Marathon Run Benefiting NBDF
-
Oct 17, 2025, 16:07WFH Volunteer Mary Byrne Transforms Bleeding Disorder Diagnostics
-
Oct 17, 2025, 08:52Erica Sparkenbaugh: Shout Out to My Doctoral Student Kylie Hutchison for Her Outstanding Oral Presentation
-
Oct 17, 2025, 08:45Shamee Shastry Shares Lean and Six Sigma in Transfusion Medicine Training Program's Success